Maurice Ayamba Itoe

Maurice Ayamba Itoe

Auto-generated profile, based on publicly available information

Maurice Ayamba Itoe

Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2022 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
FOFredros Okumu
Fredros Okumu
MGMargaret Gyapong
Margaret Gyapong
NNúria Casamitjana
Núria Casamitjana
MCMarcia Castro
Marcia Castro
MIMaurice A. Itoe
Maurice A. Itoe
MTMarcel Tanner
Marcel Tanner
After a longstanding global presence, malaria is now largely non-existent or suppressed in most parts of the world. Today, cases and deaths are primarily concentrated in sub-Saharan Africa. According to many experts, this persistence on the African continent reflects factors such as resistance to insecticides and drugs as well as insufficient access to essential commodities such as insecticide-treated nets and effective drugs. Crucially, however, this narrative ignores many central weaknesses in the fight against malaria and instead reinforces a narrow, commodity-driven vision of disease control. This paper therefore describes the core challenges hindering malaria programs in Africa and highlights key opportunities to rethink current strategies for sustainable control and elimination. The epidemiology of malaria in Africa presents far greater challenges than elsewhere and requires context-specific initiatives tailored to national and sub-national targets. To sustain progress, African countries must systematically address key weaknesses in its health systems, improve the quality and use of data for surveillance-responses, improve both technical and leadership competencies for malaria control, and gradually reduce overreliance on commodities while expanding multisectoral initiatives such as improved housing and environmental sanitation. They must also leverage increased funding from both domestic and international sources, and support pivotal research and development efforts locally. Effective vaccines and drugs, or other potentially transformative technologies such as genedrive modified mosquitoes, could further accelerate malaria control by complementing current tools. However, our underlying strategies remain insufficient and must be expanded to include more holistic and context-specific approaches critical to achieve and sustain effective malaria control.

9 May 2022 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
HMHalima Mwenesi
Halima Mwenesi
CMCharles Mbogo
Charles Mbogo
NCNúria Casamitjana
Núria Casamitjana
MCMarcia Castro
Marcia Castro
MIMaurice A. Itoe
Maurice A. Itoe
MTMarcel Tanner
Marcel Tanner
Despite considerable success in controlling malaria worldwide, progress toward achieving malaria elimination has largely stalled. In particular, strategies to overcome roadblocks in malaria control and elimination in Africa are critical to achieving worldwide malaria elimination goals—this continent carries 94% of the global malaria case burden. To identify key areas for targeted efforts, we combined a comprehensive review of current literature with direct feedback gathered from frontline malaria workers, leaders, and scholars from Africa. Our analysis identified deficiencies in human resources, training, and capacity building at all levels, from research and development to community involvement. Addressing these needs will require active and coordinated engagement of stakeholders as well as implementation of effective strategies, with malaria-endemic countries owning the relevant processes. This paper reports those valuable identified needs and their concomitant opportunities to accelerate progress toward the goals of the World Health Organization’s Global Technical Strategy for Malaria 2016–2030. Ultimately, we underscore the critical need to re-think current approaches and expand concerted efforts toward increasing relevant human resources for health and capacity building at all levels if we are to develop the relevant competencies necessary to maintain current gains while accelerating momentum toward malaria control and elimination.

22 October 2013 in Marine Drugs
Verified
Journal Article
Open access
PDF file
JSJasmine Spavieri
Jasmine Spavieri
Andrea AllmendingerAndrea Allmendinger
Andrea Allmendinger
MKMarcel Kaiser
Marcel Kaiser
MIMaurice Ayamba Itoe
Maurice Ayamba Itoe
GBGerald Blunden
Gerald Blunden
DTDeniz Tasdemir
Deniz Tasdemir
Terrestrial plants have proven to be a prolific producer of clinically effective antimalarial drugs, but the antimalarial potential of seaweeds has been little explored. The main aim of this study was to assess the in vitro chemotherapeutical and prophylactic potential of the extracts of twenty-three seaweeds collected from the south coast of England against blood stage (BS) and liver stage (LS) Plasmodium parasites. The majority (14) of the extracts were active against BS of P. falciparum, with brown seaweeds Cystoseira tamariscifolia, C. baccata and the green seaweed Ulva lactuca being the most active (IC50s around 3 μg/mL). The extracts generally had high selectivity indices (>10). Eight seaweed extracts inhibited the growth of LS parasites of P. berghei without any obvious effect on the viability of the human hepatoma (Huh7) cells, and the highest potential was exerted by U. lactuca and red seaweeds Ceramium virgatum and Halopitys incurvus (IC50 values 14.9 to 28.8 μg/mL). The LS-active extracts inhibited one or more key enzymes of the malarial type-II fatty acid biosynthesis (FAS-II) pathway, a drug target specific for LS. Except for the red seaweed Halopitys incurvus, all LS-active extracts showed dual activity versus both malarial intracellular stage parasites. This is the first report of LS antiplasmodial activity and dual stage inhibitory potential of seaweeds.

6 January 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CGCarina S. S. Gomes-Santos
Carina S. S. Gomes-Santos
MIMaurice A. Itoe
Maurice A. Itoe
CACristina Afonso
Cristina Afonso
Ricardo HenriquesRicardo Henriques
Ricardo Henriques
RGRui Gardner
Rui Gardner
MMMaria M. Mota
Maria M. Mota
Plasmodium sporozoites are transmitted by Anopheles mosquitoes and infect hepatocytes, where a single sporozoite replicates into thousands of merozoites inside a parasitophorous vacuole. The nature of the Plasmodium-host cell interface, as well as the interactions occurring between these two organisms, remains largely unknown. Here we show that highly dynamic hepatocyte actin reorganization events occur around developing Plasmodium berghei parasites inside human hepatoma cells. Actin reorganization is most prominent between 10 to 16 hours post infection and depends on the actin severing and capping protein, gelsolin. Live cell imaging studies also suggest that the hepatocyte cytoskeleton may contribute to parasite elimination during Plasmodium development in the liver.

17 December 2024 in PLOS Biology
Verified
Journal Article
Open access
PDF file
MIMaurice A Itoe
Maurice A Itoe
WSW Robert Shaw
W Robert Shaw
ISIryna Stryapunina
Iryna Stryapunina
CVCharles Vidoudez
Charles Vidoudez
DPDuo Peng
Duo Peng
FCFlaminia Catteruccia
Flaminia Catteruccia
Lipid metabolism is an essential component in reproductive physiology. While lipid mobilization has been implicated in the growth of Plasmodium falciparum malaria parasites in their Anopheles vectors, the role of this process in the reproductive biology of these mosquitoes remains elusive. Here, we show that impairing lipolysis in Anopheles gambiae, the major malaria vector, leads to embryonic lethality. Embryos derived from females in which we silenced the triglyceride lipase AgTL2 or the lipid storage droplet AgLSD1 develop normally during early embryogenesis but fail to hatch due to severely impaired metabolism. Embryonic lethality is efficiently recapitulated by exposing adult females to broad-spectrum lipase inhibitors prior to blood feeding, unveiling lipolysis as a potential target for inducing mosquito sterility. Our findings provide mechanistic insights into the importance of maternal lipid mobilization in embryonic health that may inform studies on human reproduction.

20 April 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
KAKelsey L. Adams
Kelsey L. Adams
DADaniel G. Abernathy
Daniel G. Abernathy
BWBailey C. Willett
Bailey C. Willett
ESEmily K. Selland
Emily K. Selland
MIMaurice A. Itoe
Maurice A. Itoe
FCFlaminia Catteruccia
Flaminia Catteruccia
Wolbachia infections are a fascinating example of reproductive parasitism with strong potential to combat vector-borne diseases, due to their combined ability to spread in insect populations and block pathogen replication. Though the Wolbachia factors mediating the notable reproductive manipulation cytoplasmic incompatibility (CI) have now been identified as prophage WO genes cifA and cifB , the relative role of these genes is still intensely debated, with different models claiming that CI requires either both factors or cifB alone. Here we investigated whether cifA and cifB are sufficient to induce conditional sterility in the major malaria vector Anopheles gambiae , a species that appears to have limited susceptibility to invasion by Wolbachia . We report that CI can be fully recapitulated in these mosquitoes, and that cifB is sufficient to cause this reproductive manipulation. cifB -induced sterility is fully rescued by high levels of cifA expression in females. Surprisingly, however, when cifA is highly expressed in males alongside cifB , the CI phenotype is attenuated. cifB strongly impairs fertility also when expressed in the female germline, again mitigated by cifA . These data support a system whereby cifB and cifA must be fine-tuned to exercise CI and rescue, respectively, possibly explaining the limited success of Wolbachia at invading Anopheles . Our findings pave the way towards facilitating Wolbachia infections in anopheline vectors, for use in malaria control strategies.